MUDr. Ota Hlinomaz, CSc.
Assistant professor, First Department of Internal Medicine - Cardioangiology
Total number of publications: 126
2024
-
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial
Eurointervention, year: 2024, volume: 20, edition: 20, DOI
-
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
Hellenic Journal of Cardiology, year: 2024, volume: 76, edition: March-April 2024, DOI
-
PRVNÍ ZKUŠENOSTI S TESTOVÁNÍM KORONÁRNÍ VAZOREAKTIVITY PO OBĚHOVÉ ZÁSTAVĚ Z NEJASNÉ PŘÍČINY
Year: 2024, type: Conference abstract
-
Pulsatile Left Ventricular Assistance in High-Risk Percutaneous Coronary Interventions: Short-Term Outcomes
Journal of Clinical Medicine, year: 2024, volume: 13, edition: 18, DOI
-
TROMBUS VE VALSALVOVĚ SINU S AKUTNÍM INFARKTEM MYOKARDU – KOMPLIKACE DIAGNOSTICKÉ KORONAROGRAFIE?
Year: 2024, type: Conference abstract
-
Utilization of healthcare services in acute myocardial infarction and the risk of out-of-hospital cardiac death
Panminerva medica, year: 2024, volume: 66, edition: 1, DOI
2023
-
Abstract 15489: Clinical Characteristics and Outcome of Patients With Acute Myocardial Infarction and Pre-Existing Left Heart Valvular Disease
Year: 2023, type: Conference abstract
-
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction- from the IAMI trial
American Heart Journal, year: 2023, volume: 255, edition: January 2023, DOI
-
Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis
Year: 2023, type: Conference abstract
-
CYP2C19 and CYP3A4 activity is associated with survival in ticagrelor-treated patients after ST-elevation myocardial infarction
Year: 2023, type: Conference abstract